JP2001501172A - Ｉｌ―８レセプターアンタゴニスト - Google Patents

Ｉｌ―８レセプターアンタゴニスト

Info

Publication number
JP2001501172A
JP2001501172A JP10510110A JP51011098A JP2001501172A JP 2001501172 A JP2001501172 A JP 2001501172A JP 10510110 A JP10510110 A JP 10510110A JP 51011098 A JP51011098 A JP 51011098A JP 2001501172 A JP2001501172 A JP 2001501172A
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
aryl
heteroaryl
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10510110A
Other languages
English (en)
Japanese (ja)
Inventor
ブライアン，デボラ・リン
グリーソン，ジョン・ジェラルド
ウィドーソン，キャサリン・エル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JP2001501172A publication Critical patent/JP2001501172A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10510110A 1996-08-15 1997-08-15 Ｉｌ―８レセプターアンタゴニスト Pending JP2001501172A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2398996P 1996-08-15 1996-08-15
US2399096P 1996-08-15 1996-08-15
US60/023,990 1996-08-15
US60/023,989 1996-08-15
PCT/US1997/014595 WO1998006701A1 (fr) 1996-08-15 1997-08-15 Antagonistes du recepteur de l'il-8

Publications (1)

Publication Number Publication Date
JP2001501172A true JP2001501172A (ja) 2001-01-30

Family

ID=26697888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10510110A Pending JP2001501172A (ja) 1996-08-15 1997-08-15 Ｉｌ―８レセプターアンタゴニスト

Country Status (3)

Country Link
EP (1) EP0920417A4 (fr)
JP (1) JP2001501172A (fr)
WO (1) WO1998006701A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR029637A1 (es) * 1999-05-28 2003-07-10 Smithkline Beecham Corp Compuestos de guanidina, antagonistas de los receptores de la il-8, una composicion farmaceutica que los contiene y el uso de los mismos para la manufactura de un medicamento
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
TW200418812A (en) 2002-10-29 2004-10-01 Smithkline Beecham Corp IL-8 receptor antagonists
EP1572215B1 (fr) 2002-12-20 2009-09-02 Glaxo Group Limited Derives de benzo[d]azepine pour le traitement de troubles neurologiques
ES2571220T3 (es) 2003-06-17 2016-05-24 Arena Pharm Inc Clorhidrato de 8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepina
CN1805938B (zh) 2003-06-17 2010-06-16 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
ATE442359T1 (de) 2004-12-21 2009-09-15 Arena Pharm Inc Kristalline formen von (r)-8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-be zazepinhydrochlorid
CN101466684B (zh) 2006-04-03 2012-06-20 艾尼纳制药公司 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体
BRPI0710232B8 (pt) 2006-04-21 2021-05-25 Glaxosmithkline Llc composto antagonista do receptor de il-8, composição farmacêutica que compreende o dito composto e uso do mesmo para o tratamento de uma doença mediada por quimiocina
WO2007124423A2 (fr) 2006-04-21 2007-11-01 Smithkline Beecham Corporation Antagonistes du récepteur de l'il-8
SG177128A1 (en) 2006-12-05 2012-01-30 Arena Pharm Inc Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
EP2288585A1 (fr) 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Procédés de préparation d'intermédiaires se rapportant à l'agoniste 5-ht2c (r)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
WO2011153206A1 (fr) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Procédés pour la préparation d'agonistes du récepteur 5-ht2c
EP2611433A2 (fr) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Sels non hygroscopiques d'agonistes de 5-ht2c
CN103189359A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的光学活性酸盐
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ｈｔ2ｃ 작동제의 변형-방출 투여 형태
EP2611449A1 (fr) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Administration de lorcasérine à des individus présentant une insuffisance rénale
MX2015004532A (es) 2012-10-09 2016-01-20 Arena Pharm Inc Metodo de control del peso.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
JPH0717612B2 (ja) * 1991-06-28 1995-03-01 ファイザー製薬株式会社 新規なテトラヒドロベンズアゼピン誘導体
US5441984A (en) * 1994-01-06 1995-08-15 Eli Lilly And Company Urea, thiourea and guanidine derivatives

Also Published As

Publication number Publication date
EP0920417A4 (fr) 1999-12-29
WO1998006701A1 (fr) 1998-02-19
EP0920417A1 (fr) 1999-06-09

Similar Documents

Publication Publication Date Title
US6218539B1 (en) IL-8 receptor antagonists
US6204294B1 (en) IL-8 receptor antagonists
JP2001501172A (ja) Ｉｌ―８レセプターアンタゴニスト
JP2001511130A (ja) Ｉｌ−８受容体アンタゴニスト
US6214881B1 (en) IL-8 receptor antagonists
JP2000513359A (ja) Ｉｌ―８受容体拮抗薬
JP2003525242A (ja) Ｉｌ−８受容体アンタゴニスト
JP2002515055A (ja) Ｉｌ−８受容体アンタゴニスト
US6566387B1 (en) IL-8 receptor antagonists
JP2003527360A (ja) Ｉｌ−８受容体アンタゴニスト
US6335352B1 (en) IL-8 receptor antagonists
US6248785B1 (en) IL-8 receptor antagonists
JP2000516620A (ja) Ｉｌ―８レセプターアンタゴニスト
JP2001512445A (ja) Ｉｌ−８レセプターアンタゴニスト
JP2001514217A (ja) Ｉｌ−８受容体アンタゴニスト
US6177448B1 (en) IL-8 receptor antagonists
JP2001527519A (ja) Ｉｌ―８レセプターアンタゴニスト
JP2003500443A (ja) Ｉｌ−８受容体アンタゴニスト
JP2000515495A (ja) Ｉｌ―８レセプターアンタゴニスト
JP2002509106A (ja) Ｉｌ−８受容体アンタゴニスト
JP2003501450A (ja) Ｉｌ−８受容体アンタゴニスト
JP2002513384A (ja) Ｉｌ―８受容体アンタゴニスト
US20030225125A1 (en) IL-8 receptor antagonists
JP2003501472A (ja) Ｉｌ−８受容体アンタゴニスト
WO2000073282A1 (fr) Antagonistes du recepteur d'il-8